Sight Sciences, Inc. (SGHT) Revenue Growth
Sight Sciences, Inc. (SGHT) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2022-12-31 | 45.70% |
| 2023-12-31 | 13.63% |
| 2024-12-31 | -1.47% |
| 2025-12-31 | -3.13% |
How SGHT compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| NEO | NeoGenomics Inc. | 10.11% |
| VRTX | Vertex Pharmaceuticals Incorporated | 8.90% |
| ABT | Abbott Laboratories | 5.67% |
| AZTA | Azenta Inc. | 3.55% |
| REGN | Regeneron Pharmaceuticals Inc. | 0.99% |
These are five companies in the same sector as SGHT with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Sight Sciences, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("SGHT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SGHT | $8.42 | +2.81% | 0.27M |
| 3 | ||||
| 4 | ||||
| 5 |